Cibus Global, Ltd., a biotechnology company, develops plant traits for seed industry globally. The company is headquartered in San Diego, California.
| Revenue (TTM) | $4.29M |
| Gross Profit (TTM) | $4.29M |
| EBITDA | $-53.48M |
| Operating Margin | -721.00% |
| Return on Equity | -190.10% |
| Return on Assets | -11.20% |
| Revenue/Share (TTM) | $0.08 |
| Book Value | $0.47 |
| Price-to-Book | 2.98 |
| Price-to-Sales (TTM) | 28.34 |
| EV/Revenue | 25.08 |
| EV/EBITDA | -1.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 62.60% |
| Shares Outstanding | $76.33M |
| Float | $57.18M |
| % Insiders | 26.13% |
| % Institutions | 33.60% |
Volatility is currently expanding
Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years
SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended March 31, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m.
Cibus (CBUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Represents achievement of strategic milestone for Cibus' anticipated first commercial offering in the South American market Represents achievement of strategic milestone for Cibus' anticipated first commercial offering in the South American market
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report first quarter 2026 financial results on Thursday, May 14, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m.
SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Thomas Urban to its Board of Directors.
LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cibus , Inc. , (“ Cibus " or the "Company") ( NASDAQ : CBUS ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering (the “Offering”) of 6,976,744 shares of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”) at a purchase price of $2.15 per share of Class A Common Stock.
SAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share (“Class A Common Stock”) and, in lieu of common stock to certain investors that so elect, pre-funded warrants to purchase additional shares of its Class A Common Stock in an underwritten public offering (the “Offering”). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A Common Stock offered in the Offering on the same terms and conditions.
